In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cardialen Inc.

www.cardialen.com

Latest From Cardialen Inc.

Start-Up Previews, June 2016

In this month's issue of Start-Up, we profile Ariste Medical, BioDirection, Cardialen and Homology Medicines.

BioPharmaceutical Medical Device

Cardialen Inc.

Cardialen's hybrid implantable pacemaker/defibrillator for atrial fibrillation monitors the heart beat by beat. At the first sign of arrhythmia it delivers a low-level electrical pulse to convert the patient's irregularity back to a normal heart rhythm.

Medical Device

Cardialen Inc.

Cardialen's hybrid implantable pacemaker/defibrillator for atrial fibrillation monitors the heart beat by beat. At the first sign of arrhythmia it delivers a low-level electrical pulse to convert the patient's irregularity back to a normal heart rhythm.

Medical Device

Emergings in Brief

Brief profiles of these recently formed companies: Adenios, Amedrix, Cardialen and Janisys.
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Cardialen Inc.
  • Senior Management
  • Jeff Peters, Pres. & CEO
    John Testa, CFO
    Arjun Sharma, MD, CMO
    Steve Bolea, VP, R&D
  • Contact Info
  • Cardialen Inc.
    212 Third Ave. N., Ste. 352
    Minneapolis, MN 55401
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register